Balyasny Asset Management
VRCA icon

Balyasny Asset Management’s Verrica Pharmaceuticals VRCA Stock Holding History

Balyasny Asset Management’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-6,531
Closed -$478K – 2468
2023
Q4 		$478K Buy
+6,531
New +$478K ﹤0.01% 1443